111Category: |
Intermediates/Pharmaceutical intermediates |
|
CAS NO: |
157283-68-6 |
EC NO: |
|
Molecular Formula: |
C26H35F3O6 |
Molecular Weight: |
500.5477 |
Specification: |
|
InChI: |
InChI=1/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1 |
Synonyms: |
(+/-)-16-(M-trifluoromethylphenoxy)Tetranorprostaglandin F2;15(S)-FLU-IPR;15(S)-FLUPROSTENOL ISOPROPYL ESTER;(+)-9ALPHA,11ALPHA,15R-Trihydroxy-16-(3-(trifluoromethyl)PHENOXY)-17,18,19,20-Tetranor-PROSTA-5Z,13E-DIEN-1-OIC ACID, ISOPROPYL ESTER;9ALPHA,11ALPHA,15S-Trihydroxy-16(3-(trifluoromethyl)PHENOXY)-17,18,19,20-Tetranor-PROSTA-5Z,13E-DIEN-1-OIC ACID, ISOPROPYL ESTER;(+)-FLUPROSTENOL ISOPROPYL ESTER;FLUPROSTENOL ISOPROPYL ESTER;FLU-IPR;1-methylethyl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate; |
Molecular Structure: |
|